Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
BOYLE J DAVID II
CEO at Sarepta Therapeutics. Filing since 13 Mar 2009.
CIK 0001331152
Company
Date
Role
Action
Shares
Amount
Of holding
SRPT
Sarepta Therapeutics, Inc.
27 Aug 2010
CEO
Bought
5,000
$10.65K
7.7%
SRPT
Sarepta Therapeutics, Inc.
13 Mar 2009
CFO
Bought
19,000
$12.14K
41.1%
2 decisions on file.